Marianne Andreach
Corporate Officer/Principal chez ESPERION THERAPEUTICS, INC.
Profil
Marianne Andreach is currently working as the Senior Vice President-Product Planning at Esperion Therapeutics, Inc. She previously worked as the Senior Director-Business Development at The Medicines Co. Ms. Andreach completed her undergraduate degree at the College of the Holy Cross (Massachusetts).
Postes actifs de Marianne Andreach
| Sociétés | Poste | Début |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Marianne Andreach
| Sociétés | Poste | Fin |
|---|---|---|
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/01/2004 |
Formation de Marianne Andreach
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
